🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the makers of Tylenol, asserting the companies withheld safety concerns that the pain reliever created to pediatric neurological development.

The court filing comes thirty days after President Donald Trump advocated an unverified association between using acetaminophen - alternatively called acetaminophen - throughout gestation and autism in offspring.

Paxton is taking legal action against J&J, which previously sold the drug, the sole analgesic recommended for women during pregnancy, and Kenvue, which presently makes it.

In a official comment, he stated they "deceived the public by gaining financially from pain and promoting medication regardless of the potential hazards."

Kenvue says there is no credible evidence linking acetaminophen to autism spectrum disorder.

"These manufacturers deceived for years, knowingly endangering numerous people to line their pockets," the attorney general, a Republican, stated.

The company commented that it was "very worried by the dissemination of inaccurate information on the safety of paracetamol and the possible consequences that could have on the health of American women and children."

On its online platform, Kenvue also mentioned it had "consistently assessed the applicable studies and there is lacking reliable evidence that demonstrates a established connection between using paracetamol and autism."

Organizations representing doctors and healthcare providers concur.

ACOG has stated acetaminophen - the primary component in Tylenol - is one of the few options for pregnant women to manage discomfort and fever, which can present significant medical dangers if ignored.

"In over twenty years of investigation on the use of paracetamol in pregnancy, zero credible investigations has definitively established that the usage of acetaminophen in any trimester of pregnancy results in neurological conditions in children," the association said.

The court filing mentions latest statements from the Trump administration in arguing the medication is allegedly unsafe.

Last month, the former president generated worry from health experts when he advised women during pregnancy to "fight like hell" not to take Tylenol when ill.

The FDA then released a statement that physicians should consider limiting the use of Tylenol, while also mentioning that "a direct connection" between the medication and autism spectrum disorder in minors has not been proven.

Health Secretary RFK Jr, who oversees the FDA, had promised in spring to initiate "comprehensive study program" that would establish the origin of autism in a short period.

But experts warned that identifying a sole reason of autism - thought by researchers to be the outcome of a complex mix of inherited and environmental factors - would prove challenging.

Autism spectrum disorder is a type of permanent neurological difference and disability that influences how people encounter and interact with the world, and is identified using medical professional evaluations.

In his legal document, the attorney general - a Trump ally who is running for US Senate - claims the manufacturer and Johnson & Johnson "deliberately disregarded and sought to suppress the research" around acetaminophen and autism spectrum disorder.

The case seeks to make the corporations "remove any commercial messaging" that asserts acetaminophen is safe for pregnant women.

The court case echoes the concerns of a group of guardians of young ones with autism spectrum disorder and ADHD who took legal action against the manufacturers of Tylenol in recently.

The court rejected the legal action, declaring research from the parents' expert witnesses was not conclusive.